作者:Kerry A. Ness、Sharon L. Eddie、Catherine A. Higgins、Amy Templeman、Zenobia D’Costa、Kishore K.D. Gaddale、Samira Bouzzaoui、Linda Jordan、Dominic Janssen、Timothy Harrison、Frank Burkamp、Andrew Young、Roberta Burden、Christopher J. Scott、Paul B. Mullan、Rich Williams
DOI:10.1016/j.bmcl.2015.10.001
日期:2015.12
This Letter describes the continued SAR exploration of small molecule Legumain inhibitors with the aim of developing a potent and selective in vitro tool compound. Work continued in this Letter explores the use of alternative P2-P3 linker units and the P3 group SAR which led to the identification of 10t, a potent, selective and cellularly active Legumain inhibitor. We also demonstrate that 10t has activity in both cancer cell viability and colony formation assays. (C) 2015 Elsevier Ltd. All rights reserved.